Soft Tissue Repair Scaffolds
Not Specified
Pre-clinicalActive
Key Facts
About Maana Discoveries
Maana Discoveries is a private, preclinical-stage biotech firm developing biomaterial-based solutions for drug delivery and soft tissue repair. Leveraging a biopolymer technology platform, the company aims to create products that are easier to use, scalable to manufacture, and less reliant on cold-chain logistics, targeting significant gaps in global healthcare access. Led by co-founders with strong academic and industry experience in biomaterials and medical devices, Maana is positioned to translate innovative research into meaningful commercial products. Its mission centers on making treatments more accessible, safe, and affordable worldwide.
View full company profileOther Not Specified Drugs
| Drug | Company | Phase |
|---|---|---|
| FL116 | Forlong Biotechnology | Not specified |
| FL117 | Forlong Biotechnology | Not specified |
| FL118 | Forlong Biotechnology | Not specified |
| FL301 | Forlong Biotechnology | Not specified |
| JSKN016 | AlphaMab Oncology | Phase 1 |
| JSKN033 | AlphaMab Oncology | Phase 1 |
| JSKN022 | AlphaMab Oncology | Phase 1 |
| JSKN027 | AlphaMab Oncology | Phase 1 |
| KN019 | AlphaMab Oncology | Phase 1 |
| New TCM Formulations | China SXT Pharmaceuticals | Research / Pre-clinical |
| Long-acting Leronlimab | CytoDyn | Preclinical |
| SR2162 | SIMR (Australia) Biotech | IND Approved |